Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Citigroup analysts made contrasting calls on Monday. They cut Accenture from Buy to Hold. The target price fell sharply — from $215 to $195. That is a 9% drop in the price target. Accenture trades near $115 billion in market cap and carries 4.1% SI % FF.
The same bank turned bullish on General Motors. Citigroup raised its GM target from $108 to $131 — a $23 jump. The Buy rating holds. GM trades near a $75 billion market cap.
AppLovin also drew fresh Buy coverage from Citigroup's Jason Bazinet. The target price is $710. AppLovin is a $187 billion ad-tech firm. Short interest sits at just 5% of free float.
UBS cut its target on lululemon athletica from $176 to $153. Analyst Jay Sole kept the Hold rating. Lululemon has faced slowing growth in North America. Short interest at 6.1% of free float reflects ongoing bearishness.
C.H. Robinson got a brighter outlook from UBS. Thomas Wadewitz raised the freight broker's target from $224 to $230. The rating stays Buy.
Abbott Laboratories received an upgrade from Wall Street analysts. The consensus shifted upward. The average target price is $117. MGM Resorts saw one downgrade. Its consensus slipped to a more cautious stance with an average target near $45.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
